4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001628280-25-007699
EVP and Chief Medical Officer acquired 40,000 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Eisner Mark EVP and Chief Medical Officer | 2025-02-22 | Grant or award 10b5-1 | +40,000 | 115,000 | D | ||
| Derivatives | |||||||
| Eisner Mark EVP and Chief Medical Officer | 2025-02-22 | Grant or award · Stock Option (Right to Buy) 10b5-1 | +80,000 | 80,000 | D | ||
Loading xslF345X05/wk-form4_1740515940.xml…